Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

AmerisourceBergen Unit Receives Global Good Distribution Practice Certification

By AmerisourceBergen Corp. | January 15, 2018

World Courier, a specialty logistics unit of AmerisourceBergen, achieved Good Distribution Practice (GDP) certification across its global network of 140-plus offices. 

DQS, a certification body for management systems worldwide, conducted a six–month evaluation process, during which a team of auditors analyzed World Courier’s transportation, handling, and storage processes, and tested them against guidelines outlined by the European Union (EU GDP Guidelines), United States Pharmacopeia (USP 1079), and World Health Organization (WHO GDP).

GDP guidelines regulate the distribution of medicinal products from the manufacturer to the patient.

World Courier is the first logistics company to attain global GDP certification against three major GDP standards with international implications and the only provider to hold a GDP certification with such wide and global scope, accordng to the company.  

“With the increased globalization of supply chains and the emergence of high-value products, such as cell and gene therapies, there is a heightened demand for strict quality and temperature control measures to ensure product quality and integrity throughout long-distance deliveries,” Sam Herbert , World Courier president, said. 

The AmerisourceBergen unit maintains company-owned offices in more than 50 countries, with 14 investigational drug depots located in emerging markets worldwide.

(Source: AmerisourceBergen)

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE